In vitro fertilization (IVF) is a process of fertilization where an egg is combined with sperm outside the body i.e., in vitro. The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or eggs from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
Some infertile patients undergoes IVF cycles and produce embryos, but the embryos consistently fail to implant for unexplained reasons. This is called IVF failure or implantation failure. This is a very frustrating problem both for patients and for doctors. Some common reasons why an IVF cycle fails are:
Despite in advanced reproductive technologies and great improvement in infertility treatment, implantation failure is one of the major challenges. The receptive Endometrium is the main factor for implantation and pregnancy. Implansera Treatments is a promising treatment and it is extremely safe since it’s drawn from the patient's own blood which stimulates the growth factors and they regulate various cellular mechanisms and is effective in improvement of pregnancy outcome.
Implansera Treatments is prepared from fresh peripheral blood which is aspirated from a peripheral vein, stored in anticoagulant and processed to increase platelets by separating various components in blood. In a normal menstrual cycle in human, Endometrium becomes receptive during the mid secretary phase around days 19-23 that is described as window of implantation. During this period, cytokines, growth factors, prostaglandins, and adhesion molecules are expressed and inconsistency of these compounds could impair implantation and pregnancy. But Implansera Treatments helps them stimulate and increase the chances of IVF success.